Skip to main content
. 2022 Jun 9;19(2):401–414. doi: 10.1080/15548627.2022.2084862

Table 1.

The role of mitophagy in various pathological conditions of acute kidney injury.

Pathways Factors Model Cells and Animals Mechanisms Effect Reference
PRKN-dependent IRI CCCP for HK-2 cells and IRI for mice PINK1 siRNA, PRKN siRNA, or double siRNA in cells; pink1-KO, prkn-KO or double-KO in mice. 1. Reduce mitochondrial damage
2. Modulate the removal of ROS
3. Relieve inflammatory response
4. Modulate cell death
Activation of mitophagy protects against AKI [65]
IRI H/R for HK-2 cells and IRI for mice PmirGLO-Dual-luciferase reporter vector of MEG3 and RTKN in cells;
AAV-sh-MEG3 vector in mice via tail vein.
Promoting apoptosis Activation of mitophagy aggravates AKI [66]
IRI CCCP for RPTC cells and IRI for mice Pink1 shRNA in cells
PT-atg7-KO in mice
1.Suppressed mitochondrial depolarization
2.Improved ATP production
3.Inhibited the generation of ROS
Activation of mitophagy protects against AKI [72]
Sepsis LPS for RPTC cells and LPS or CLP for mice Pink1 siRNA, Prkn siRNA, or Optn siRNA in cells; pink1-KO or prkn KO in mice 1. Mitochondrial quality control
2. Reduce cells apoptosis
Activation of mitophagy protects against AKI [81]
Sepsis LPS for RPTC cells Pink1 siRNA and Prkn siRNA in cells 1. Inhibited the apoptosis
2. Remove damaged mitochondria
Activation of mitophagy protects against AKI [82]
Sepsis LPS for HK-2 cells and CLP for rats PRKN siRNA or SIRT1 inhibitor in HK-2 cells; Prkn silencing lentivirus and SIRT1 inhibitor EX527 in rats via tail vein 1. Inhibited the apoptosis
2. Inhibited the pyroptosis
3. Remove damaged mitochondria
Activation of mitophagy protects against AKI [83]
Sepsis CLP for mice prkn-KO in mice 1. Inhibition of mitochondrial dysfunction
2. Inhibition of NLRP3 inflammasome activation
Activation of mitophagy protects against AKI [84]
Cisplatin Cisplatin injected intraperitoneally for mice pink1-KO or prkn-KO in mice Reduce cells apoptosis Activation of mitophagy protects against AKI [87]
Cisplatin Cisplatin for RTECs and cisplatin injected intraperitoneally for mice - 1. Reversed cellular ROS induced by cisplatin
2. Reversed mitochondrial membrane potential level induced by cisplatin
Activation of mitophagy protects against AKI [88]
Cisplatin Cisplatin for HK-2 PINK1 siRNA, PRKN siRNA and PINK1 or PRKN overexpression plasmids in HK-2 1. Protected against mitochondrial dysfunction
2. Protected against cell injury
Activation of mitophagy protects against AKI [89]
Cisplatin Intraperitoneal injection of cisplatin for rats pink1-KO in rats 1. PINK1 deficiency inhibited DNM1L-mediated mitochondrial fission
2. PINK1 deficiency inhibited excessive mitophagy
Excessive mitophagy aggravates AKI [90]
Contrast Iohexol for HK-2 and iohexol administration for mice PINK1 siRNA or PRKN siRNA in cells; pink1-KO or prkn-KO in mice 1. Reduce mitochondrial ROS
2. Reduce NLRP3 inflammasome activation
Activation of mitophagy protects against AKI [91]
Contrast Ioversol for HK-2 and ioversol for rats - 1. Reduce oxidative stress
2. Reduce mitochondrial damage
Activation of mitophagy protects against AKI [94]
PRKN-independent IRI OGD-R for BUMPT cells and IRI for mice Bnip3 silence in cells; bnip3-KO in mice 1. Eliminate damaged mitochondria
2. Modulate the removal of ROS
3. Modulate cell death
4. Relieve inflammatory response
Activation of mitophagy protects against AKI [64]
IRI IRI for rats Mdivi-1, an inhibitor of DNM1L, in rats 1. Mitophagic clearance of damaged mitochondria
2. Protects cells apoptosis.
Activation of mitophagy protects against AKI [73]
IRI IRI for mice cnp-KO in mice. Aggressive removal of injured mitochondria Activation of mitophagy protects against AKI [74]
IRI H/R for HK-2 cells and IRI for mice HIF1A siRNA, BNIP3 siRNA, and BNIP3-overexpression plasmid for cell; hif1a-CKO and bnip3-overexpression adenovirus in mice 1. Inhibited apoptosis
2. Inhibited ROS production
Activation of mitophagy protects against AKI [75]
IRI IRI for mice and rotenone for primary tubule cells fundc1-PTKO, dnm1l-PTKO, ulk1-PTKO and fundc1-dnm1l-PTKO in mice 1. Mitochondrial quality control
2. Reduce ROS oxidative stress
3. Reduce mitochondrial apoptosis
Activation of mitophagy protects against AKI [76]
Contrast Iohexol for HK-2 and iohexol administration for mice BNIP3 siRNA in cells; bnip3-KO in mice Reduce cells apoptosis Activation of mitophagy protects against AKI [93]